These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25493427)

  • 81. Regional mu-opioid receptor binding in insular cortex is decreased in bulimia nervosa and correlates inversely with fasting behavior.
    Bencherif B; Guarda AS; Colantuoni C; Ravert HT; Dannals RF; Frost JJ
    J Nucl Med; 2005 Aug; 46(8):1349-51. PubMed ID: 16085593
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
    Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE
    J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial.
    Ray R; Jepson C; Wileyto EP; Dahl JP; Patterson F; Rukstalis M; Pinto A; Berrettini W; Lerman C
    Nicotine Tob Res; 2007 Nov; 9(11):1237-41. PubMed ID: 17978999
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [11C]Carfentanil Binds Preferentially to μ-Opioid Receptor Subtype 1 Compared to Subtype 2.
    Eriksson O; Antoni G
    Mol Imaging; 2015; 14():476-83. PubMed ID: 26461068
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.
    Rose JE; Behm FM; Westman EC
    Pharmacol Biochem Behav; 2001 Feb; 68(2):187-97. PubMed ID: 11267622
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Robust age, but limited sex, differences in mu-opioid receptors in the rat brain: relevance for reward and drug-seeking behaviors in juveniles.
    Smith CJW; Ratnaseelan AM; Veenema AH
    Brain Struct Funct; 2018 Jan; 223(1):475-488. PubMed ID: 28871491
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Evaluating nicotine dependence levels in e-cigarette users.
    González Roz A; Secades Villa R; Weidberg S
    Adicciones; 2017 Jan; 29(2):136-138. PubMed ID: 28170058
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Obesity is associated with decreased μ-opioid but unaltered dopamine D2 receptor availability in the brain.
    Karlsson HK; Tuominen L; Tuulari JJ; Hirvonen J; Parkkola R; Helin S; Salminen P; Nuutila P; Nummenmaa L
    J Neurosci; 2015 Mar; 35(9):3959-65. PubMed ID: 25740524
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Feeding Releases Endogenous Opioids in Humans.
    Tuulari JJ; Tuominen L; de Boer FE; Hirvonen J; Helin S; Nuutila P; Nummenmaa L
    J Neurosci; 2017 Aug; 37(34):8284-8291. PubMed ID: 28747384
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Endogenous cannabinoid and opioid systems and their role in nicotine addiction.
    Maldonado R; Berrendero F
    Curr Drug Targets; 2010 Apr; 11(4):440-9. PubMed ID: 20017727
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Metabotropic glutamate receptor 5 as a potential target for smoking cessation.
    Chiamulera C; Marzo CM; Balfour DJK
    Psychopharmacology (Berl); 2017 May; 234(9-10):1357-1370. PubMed ID: 27847973
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A gene-by-sex interaction for nicotine reward: evidence from humanized mice and epidemiology.
    Bernardi RE; Zohsel K; Hirth N; Treutlein J; Heilig M; Laucht M; Spanagel R; Sommer WH
    Transl Psychiatry; 2016 Jul; 6(7):e861. PubMed ID: 27459726
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Endogenous opioid release in the human brain reward system induced by acute amphetamine administration.
    Colasanti A; Searle GE; Long CJ; Hill SP; Reiley RR; Quelch D; Erritzoe D; Tziortzi AC; Reed LJ; Lingford-Hughes AR; Waldman AD; Schruers KR; Matthews PM; Gunn RN; Nutt DJ; Rabiner EA
    Biol Psychiatry; 2012 Sep; 72(5):371-7. PubMed ID: 22386378
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating.
    Majuri J; Joutsa J; Johansson J; Voon V; Alakurtti K; Parkkola R; Lahti T; Alho H; Hirvonen J; Arponen E; Forsback S; Kaasinen V
    Neuropsychopharmacology; 2017 Apr; 42(5):1169-1177. PubMed ID: 27882998
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Genetic and Depressive Traits Moderate the Reward-Enhancing Effects of Acute Nicotine in Young Light Smokers.
    Whitton AE; Rabinovich NE; Lindt JD; Pergadia ML; Pizzagalli DA; Gilbert DG
    Nicotine Tob Res; 2021 Aug; 23(10):1779-1786. PubMed ID: 33844007
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The influence of conditioned stimuli on [
    Di Ciano P; de Wit H; Mansouri E; Houle S; Boileau I; Le Foll B
    Sci Rep; 2021 Jun; 11(1):11667. PubMed ID: 34083612
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Response of the μ-opioid system to social rejection and acceptance.
    Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Wang H; Ni L; Walker SJ; Mickey BJ; Korycinski ST; Koeppe RA; Crocker JK; Langenecker SA; Zubieta JK
    Mol Psychiatry; 2013 Nov; 18(11):1211-7. PubMed ID: 23958960
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The Effects of Intramuscular Naloxone Dose on Mu Receptor Displacement of Carfentanil in Rhesus Monkeys.
    Scott PJH; Koeppe RA; Shao X; Rodnick ME; Sowa AR; Henderson BD; Stauff J; Sherman PS; Arteaga J; Carlo DJ; Moss RB
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32192089
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans.
    Love TM; Stohler CS; Zubieta JK
    Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effects of amphetamine on the human brain opioid system--a positron emission tomography study.
    Guterstam J; Jayaram-Lindström N; Cervenka S; Frost JJ; Farde L; Halldin C; Franck J
    Int J Neuropsychopharmacol; 2013 May; 16(4):763-9. PubMed ID: 22932428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.